Moist Wound Dressings Market by Product, Application, End User, and Region 2025-2033
상품코드:1635985
리서치사:IMARC
발행일:2025년 01월
페이지 정보:영문 123 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
습윤 상처 드레싱 시장의 세계 시장 규모는 2024년에 52억 달러에 달했습니다. 향후 IMARC Group은 2033년까지 이 시장이 77억 달러에 달할 것으로 예상하며, 2025-2033년 연평균 성장률(CAGR)은 4.19%에 달할 것으로 예측합니다. 의료 전문가, 환자 및 간병인의 인식 증가, 의료 제품 및 치료의 보급, 의료비 상환 정책, 수술 기술의 발전 등이 시장을 이끄는 주요 요인으로 꼽힙니다.
습윤 상처 드레싱은 보다 빠르고 효과적인 치유를 촉진하기 위해 습윤 환경을 조성하는 첨단 상처 관리 솔루션의 일종입니다. 이 드레싱은 상처 부위에 수분을 유지하거나 공급하여 자가 용해성 박리 및 세포 증식과 같은 자연 치유 과정을 촉진합니다. 알긴산, 하이드로콜로이드, 하이드로겔, 폼 등의 재료로 구성되며, 젤, 크림, 필름 등 다양한 형태로 제공됩니다. 상처를 촉촉한 상태로 유지함으로써 흉터와 조직 손상을 줄이고, 통증을 완화하며, 상처의 건조와 치유를 지연시키는 딱지 형성을 방지할 수 있습니다. 습윤 상처 드레싱은 상처를 감염으로부터 보호하고 삼출물을 흡수하는 기능이 있어 만성 상처, 수술 상처, 화상, 궤양에 이상적입니다. 따라서 습윤 상처 드레싱은 최적의 상처 치유 상태를 촉진하는 데 중요한 역할을 합니다.
인구 증가, 평균 수명 증가, 만성질환의 유행 등의 요인으로 인해 의료비 지출은 지속적으로 증가하고 있습니다. 의료비 지출이 증가함에 따라 상처 관리 관리에 대한 자원 배분이 증가하고 있습니다. 또한 습윤 상처 드레싱의 장점에 대한 의료 전문가, 환자 및 간병인의 인식이 높아지고 있습니다. 의료 단체와 상처 관리 협회에서 시행하는 교육 이니셔티브, 교육 프로그램 및 인식 개선 캠페인은 습윤 상처 드레싱의 이점에 대한 지식을 전파하는 데 큰 역할을 하고 있습니다. 이와는 별도로, 의료 제품 및 치료법의 채택에 큰 영향을 미치는 것은 상환 정책 및 보험 적용입니다. 습윤 상처 드레싱에 대한 우호적 인 상환 정책은 의료 서비스 제공자가 이러한 제품을 처방하고 사용하도록 장려하고 있습니다. 또한, 수술 기술의 발전과 최소침습 수술로의 전환은 이러한 접근 방식에 적합한 습윤 상처 드레싱에 대한 수요에 기여하고 있습니다. 수술 건수의 증가는 습윤 상처 드레싱 시장 성장을 주도하고 있습니다.
습윤 상처 드레싱 시장 동향/촉진요인:
만성 상처의 증가
욕창, 당뇨성 족부궤양, 정맥성 하지궤양과 같은 만성 상처는 전 세계적으로 심각한 의료 문제가 되고 있습니다. 고령화, 당뇨병 유병률의 증가, 운동 능력이 낮은 인구의 증가는 만성 상처의 유병률 증가에 한 몫을 하고 있습니다. 습윤 상처 드레싱은 최적의 치유 환경을 조성할 수 있기 때문에 만성 상처 관리를 위한 효과적인 치료 옵션으로 주목받고 있습니다. 습윤 상처 드레싱은 습윤 환경을 유지하고, 상처의 탈피를 촉진하며, 육아조직의 형성을 촉진하여 상처 치유 과정을 촉진합니다. 만성 상처 환자층의 확대는 습윤 상처 드레싱의 시장 수요를 견인할 것으로 예상됩니다.
비용 효율적인 상처 관리에 대한 관심 증가
최근 전 세계 의료 시스템은 양질의 의료 서비스를 제공하면서도 비용 절감을 위해 노력하고 있습니다. 이에 따라 비용 효율적인 상처 관리 솔루션에 대한 관심이 높아지고 있습니다. 습윤 상처 드레싱은 거즈 드레싱과 같은 전통적인 상처 관리 방법에 비해 비용 효율적이기 때문에 인기를 끌고 있습니다. 습윤 상처 드레싱은 교체 횟수가 적고, 상처 오염의 위험을 최소화하며, 추가 치료의 필요성을 줄여 전반적인 비용 절감으로 이어집니다. 또한, 습윤 상처 드레싱은 환자의 편안함과 편의성을 향상시켜 치료 요법에 대한 순응도를 높일 수 있습니다. 습윤 상처 드레싱과 관련된 비용 효율성과 잠재적인 비용 절감 효과로 인해 의료 현장에서 습윤 상처 드레싱의 채택이 확대될 것으로 예상됩니다.
습윤 상처 드레싱의 기술적 진보
습윤 상처 드레싱 시장은 지속적인 기술 혁신과 기술적 진보를 경험하고 있습니다. 제조업체들은 우수한 습도 관리, 통기성 향상, 삼출물 흡수 개선, 착용 시간 연장을 위한 첨단 드레싱 개발에 주력하고 있습니다. 하이드로겔, 폼, 필름, 알긴산 등 첨단 드레싱이 습윤 상처 드레싱에 접목되어 상처 치유 효과를 높이고 있습니다. 또한, 드레싱에 항균제를 함유하여 상처 감염 방지에도 도움을 주고 있습니다. 습윤 상처 드레싱의 기술적 발전은 환자의 편안함과 순응도를 향상시킬 뿐만 아니라 치유율 향상에도 기여하고 있습니다. 의료 전문가와 환자들이 이러한 첨단 제품을 알게 되면서 습윤 상처 드레싱에 대한 수요가 증가하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
조사 목적
이해관계자
데이터 소스
1차 정보
2차 정보
시장 추정
상향식 접근
하향식 접근
조사 방법
제3장 주요 요약
제4장 소개
개요
주요 업계 동향
제5장 세계의 습윤 상처 드레싱 시장
시장 개요
시장 실적
COVID-19의 영향
시장 예측
제6장 시장 내역 : 제품별
폼 드레싱
시장 동향
시장 예측
하이드로콜로이드 드레싱
시장 동향
시장 예측
필름 드레싱
시장 동향
시장 예측
알긴산염 드레싱
시장 동향
시장 예측
하이드로겔 드레싱
시장 동향
시장 예측
콜라겐 드레싱
시장 동향
시장 예측
기타
시장 동향
시장 예측
제7장 시장 내역 : 용도별
급성 상처
시장 동향
주요 부문
외과수술·외상 상처
화상
시장 예측
만성 상처
시장 동향
주요 부문
당뇨병성 족부궤양
욕창
정맥성 다리궤양
기타
시장 예측
제8장 시장 내역 : 최종사용자별
병원
시장 동향
시장 예측
전문 클리닉
시장 동향
시장 예측
재택의료
시장 동향
시장 예측
기타
시장 동향
시장 예측
제9장 시장 내역 : 지역별
북미
미국
캐나다
아시아태평양
중국
일본
인도
한국
호주
인도네시아
기타
유럽
독일
프랑스
영국
이탈리아
스페인
러시아
기타
라틴아메리카
브라질
멕시코
기타
중동 및 아프리카
제10장 촉진요인, 억제요인, 기회
개요
성장 촉진요인
성장 억제요인
기회
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
개요
구매자의 교섭력
공급 기업의 교섭력
경쟁 정도
신규 참여업체의 위협
대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
시장 구조
주요 기업
주요 기업 개요
3M Company
Advanced Medical Solutions Group plc
B. Braun Medical Inc.
Cardinal Health Inc.
Coloplast A/S
Convatec Inc.
Hartmann AG
Hollister Incorporated
Lohmann & Rauscher
Medline Industries Inc.
Molnlycke Health Care AB
Scapa Group Limited
Smith & Nephew Plc
ksm
영문 목차
영문목차
The global moist wound dressings market size reached USD 5.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.19% during 2025-2033. The rising awareness among healthcare professionals, patients, and caregivers, the widespread adoption of medical products and treatments due to reimbursement policies, and the advancements in surgical techniques are some of the major factors propelling the market.
Moist wound dressings are a type of advanced wound care solution that fosters a moist environment to facilitate faster, more effective healing. These dressings can retain or donate moisture to the wound bed, encouraging natural healing processes, including autolytic debridement and cell proliferation. They're comprised of materials such as alginates, hydrocolloids, hydrogels, or foams, and they come in various forms including gels, creams, films, and more. By keeping the wound moist, these dressings aid in the reduction of scarring and tissue damage, reduce pain, and prevent the wound from drying out and forming a scab, which can delay healing. Moist wound dressings also assist in protecting the wound from infection and absorbing exudate, making them ideal for chronic wounds, surgical wounds, burns, and ulcers. Therefore, moist wound dressings play a crucial role in promoting optimal wound healing conditions.
Healthcare expenditure continues to rise due to factors such as population growth, increasing life expectancy, and the prevalence of chronic diseases. As healthcare spending increases, there is a greater allocation of resources toward wound care management. In addition, the rising awareness among healthcare professionals, patients, and caregivers regarding the benefits of moist wound dressings. Educational initiatives, training programs, and awareness campaigns conducted by healthcare organizations and wound care associations have played a significant role in disseminating knowledge about the advantages of moist dressings. Apart from this, reimbursement policies and insurance coverage significantly impact the adoption of medical products and treatments. Favorable reimbursement policies for moist wound dressings encourage healthcare providers to prescribe and utilize these products. Furthermore, advancements in surgical techniques and a shift towards minimally invasive procedures contribute to the demand for moist dressings, as they are compatible with these approaches. The increasing volume of surgical procedures drives the market growth for moist wound dressings.
Moist Wound Dressings Market Trends/Drivers:
Increasing Prevalence of Chronic Wounds
Chronic wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers, have become a significant healthcare challenge worldwide. Along with this, the aging population, rising incidence of diabetes, and a growing number of individuals with limited mobility contribute to the increasing prevalence of chronic wounds. Moist wound dressings have gained prominence as an effective treatment option for managing chronic wounds due to their ability to create an optimal healing environment. These dressings maintain a moist environment, facilitate wound debridement, and enhance the wound healing process by promoting granulation tissue formation. The expanding patient pool with chronic wounds is expected to drive the demand for moist wound dressings in the market.
Growing Emphasis on Cost-effective Wound Management
In recent years, healthcare systems across the globe have been striving to contain costs while delivering quality care. As a result, there is a growing emphasis on cost-effective wound management solutions. Moist wound dressings are gaining popularity due to their cost-effectiveness compared to traditional wound care methods, such as gauze dressings. Moist dressings require fewer changes, minimize the risk of wound contamination, and reduce the need for additional treatments, resulting in overall cost savings. Additionally, moist wound dressings offer improved patient comfort and convenience, leading to better compliance with treatment regimens. The cost-effectiveness and potential savings associated with moist wound dressings are expected to drive their adoption in healthcare settings.
Technological Advancements in Moist Wound Dressings
The market for moist wound dressings is experiencing continuous innovation and technological advancements. Manufacturers are focusing on developing advanced dressings that offer superior moisture management, enhanced breathability, improved exudate absorption, and prolonged wear time. Advanced dressing materials such as hydrogels, foams, films, and alginates are being incorporated into moist wound dressings to provide better wound-healing outcomes. Moreover, the integration of antimicrobial agents into dressings helps combat wound infections. Technological advancements in moist wound dressings not only improve patient comfort and compliance but also contribute to better healing rates. As healthcare professionals and patients become aware of these advanced products, the demand for moist wound dressings is contributing to the market.
Moist Wound Dressings Industry Segmentation:
Product Insights:
Foam Dressings
Hydrocolloid Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Collagen Dressings
Others
Foam dressings dominate the market
Foam dressings have emerged as a popular product in the moist wound dressings industry, and their market growth is driven by several factors. Additionally, foam dressings offer excellent absorption capabilities, effectively managing moderate to heavily exuding wounds. The ability to absorb and lock away excess wound fluid reduces the risk of maceration and promotes a moist wound environment conducive to healing. In addition, foam dressings provide a cushioning effect, protecting the wound from external trauma and minimizing pain. This feature makes them particularly suitable for pressure ulcers, surgical wounds, and other injuries requiring extra protection. Furthermore, foam dressings are highly versatile, easily conforming to wound contours, and can be used on both shallow and deep wounds. Furthermore, advancements in foam dressing technology, such as the incorporation of silver or other antimicrobial agents, further enhance their efficacy in preventing and managing wound infections.
Application Insights:
Acute Wounds
Surgical and Traumatic Wounds
Burns
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Others
Chronic wounds hold the largest share in the market
The application of moist wound dressings in the management of chronic wounds is driven by the increasing prevalence of chronic wounds, including pressure ulcers, diabetic foot ulcers, and venous leg ulcers, which is a significant driver. The aging population, rising incidence of diabetes, and lifestyle factors contribute to the growing burden of chronic wounds, necessitating effective treatment options. Moist wound dressings create an optimal healing environment, promoting granulation tissue formation and facilitating the wound healing process. In addition, the technological advancements in moist wound dressings specifically tailored for chronic wounds fuel their market growth. These advancements include dressings with enhanced moisture management, improved exudate absorption, and prolonged wear time, all of which contribute to better healing outcomes. Moreover, the emphasis on cost-effective wound management is a crucial driver for moist wound dressings in chronic wound applications.
End User Insights:
Hospitals
Specialty Clinics
Homecare
Others
Hospitals dominate the market
The application of moist wound dressings in hospitals is driven by the escalating number of patients with acute and chronic wounds. The rising demand for moist wound dressings in hospitals is due to the need to provide effective wound care and promote optimal healing outcomes. Along with this, hospitals strive to enhance patient comfort and satisfaction while delivering quality care. Moist wound dressings offer advantages such as improved pain management, reduced risk of infection, and enhanced wound healing, which contribute to better patient experiences. Moreover, hospitals focus on infection control and prevention, and moist dressings with antimicrobial properties help address this concern by minimizing the risk of wound infections. Additionally, it helps maintain an ideal moisture balance in the wound bed, which is crucial for promoting healing. It can either retain moisture in dry wounds or absorb excess moisture in heavily exuding wounds, ensuring the right level of moisture for optimal healing.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest moist wound dressings market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The moist wound dressings industry in North America is driven by several market drivers. The region has a high prevalence of chronic diseases such as diabetes, obesity, and cardiovascular conditions, which contribute to the increasing incidence of chronic wounds. Along with this, the growing aging population in North America further fuels the demand for moist wound dressings as this demographic is more prone to chronic wounds. In addition, North America has a well-established healthcare infrastructure with advanced wound care facilities and a strong emphasis on quality patient care. Healthcare providers in the region recognize the benefits of moist wound dressings in promoting faster healing, reducing complications, and improving patient outcomes. Furthermore, technological advancements and innovations in the field of wound care are prevalent in North America.
Competitive Landscape:
The global moist wound dressings market is experiencing significant growth due to the development of advanced products to offer better wound care solutions. This includes hydrogels, hydrocolloids, alginates, and foam dressings that promote moist wound healing. Along with this, the escalating number of partnerships and collaborations to enhance research and development efforts, expand geographical reach, or combine resources and expertise to create new products is significantly supporting the market. In addition, companies are providing training and educational resources for healthcare professionals and patients to understand the advantages of moist wound healing, significantly supporting the marketing. With the rise of digital health and telemedicine, some companies are working on integrating their products with digital health platforms to enhance patient monitoring and care.
The report has provided a comprehensive analysis of the competitive landscape in the global moist wound dressings market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
3M Company
Advanced Medical Solutions Group plc
B. Braun Medical Inc.
Cardinal Health Inc.
Coloplast A/S
Convatec Inc.
Hartmann AG
Hollister Incorporated
Lohmann & Rauscher
Medline Industries Inc.
Molnlycke Health Care AB
Scapa Group Limited
Smith & Nephew Plc
Key Questions Answered in This Report:
How has the global moist wound dressings market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global moist wound dressings market?
What is the impact of each driver, restraint, and opportunity on the global moist wound dressings market?
What are the key regional markets?
Which countries represent the most attractive moist wound dressings market?
What is the breakup of the market based on the product?
Which is the most attractive product in the moist wound dressings market?
What is the breakup of the market based on the application?
Which is the most attractive application in the moist wound dressings market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the moist wound dressings market?
What is the competitive structure of the global moist wound dressings market?
Who are the key players/companies in the global moist wound dressings market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Moist Wound Dressings Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Foam Dressings
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hydrocolloid Dressings
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Film Dressings
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Alginate Dressings
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Hydrogel Dressings
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Collagen Dressings
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Application
7.1 Acute Wounds
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Surgical and Traumatic Wounds
7.1.2.2 Burns
7.1.3 Market Forecast
7.2 Chronic Wounds
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Diabetic Foot Ulcers
7.2.2.2 Pressure Ulcers
7.2.2.3 Venous Leg Ulcers
7.2.2.4 Others
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Specialty Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Homecare
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Advanced Medical Solutions Group plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 B. Braun Medical Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Cardinal Health Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Coloplast A/S
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Convatec Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Hartmann AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Hollister Incorporated
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Lohmann & Rauscher
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Medline Industries Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 SWOT Analysis
14.3.11 Molnlycke Health Care AB
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.12 Scapa Group Limited
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 SWOT Analysis
14.3.13 Smith & Nephew Plc
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.